Skip to main content
. 2022 Aug 23;37(1):2265–2282. doi: 10.1080/14756366.2022.2104841

Figure 14.

Figure 14.

3D diagram of compounds 10b (A) and 10d (B) showing their binding interaction with the VEGFR-2 active site (PDB: 4ASD).